Immunomodulatory activities associated with β-glucan derived from Saccharomyces cerevisiae

Physiological Research

Volumn 54, Issue 5, 2005, Pages 557-564

  Pelizon, A C ^a   Kaneno, R ^a   Soares, A M V C ^a   Meira, D A ^a   Sartori, A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

glucan; Fungicidal activity; IL 12; NK activity; TNF

Indexed keywords

BETA GLUCAN; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; FUNGICIDAL ACTIVITY; IMMUNOMODULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERITONEUM CELL; SACCHAROMYCES CEREVISIAE; SPLEEN CELL; TARGET CELL;

ANIMALS; ANTIFUNGAL AGENTS; BETA-GLUCANS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOLOGIC FACTORS; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; PARACOCCIDIOIDES; SACCHAROMYCES CEREVISIAE;

EID: 27644525584     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. ABEL G, CZOP JK: Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β. Int J Immunopharmacol 14: 1363-1373, 1992.
2. ADAMS DS, PERO SC, PETRO JB, NATHANS R, MACKIN WM, WAKSHULL E: PGG-glucan activates NF-kappa B-like and NF-IL-6-like transcription factor complexes in a murine monocytic cell line. J Leukoc Biol 62: 865-873, 1997.
3. ANJOS AR, CALVI SA, FERRACINI R, PERAÇOLI MTS, SILVA CL, SOARES AMVC: Role of Paracoccidioides brasiliensis cell wall fraction containing beta-glucan in tumor necrosis factor-alpha production by human monocytes: correlation with fungicidal activity. Med Mycol 40: 337-382, 2002.
4. AU BT, WILLIAMS TJ, COLLINS PD: Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator. J Immunol 152: 5411-5419, 1994.
5. BATTLE J, HA T, LI C, DELLA BEFFA V, RICE P, KALBFLEISCH J, BROWDER W, WILLIAMS D: Ligand binding to the (1→3)-beta-D-glucan receptor stimulates NFκB activation, but not apoptosis in U937 cells. Biochem Biophys Res Commun 249: 499-504, 1998.
6. BENACH JL, HABICHT GS, HOLBROOK TW, COOK JA: Glucan as an adjuvant for a murine Babesia microti immunization trial. Infect Immun 35: 947-951, 1982.
7. BORGES-WALMSLEY MI, CHEN D, SHU X, WALMSLEY AR: The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol 10: 80-87, 2002.
8. BROWDER IW, WILLIAMS DL, KITAHAMA A, DI LUZIO NR: Modification of post-operative C. albicans sepsis by glucan immunostimulation. Int J Immunopharmacol 6: 19-26, 1984.
9. BROWN GD, GORDON S: Fungal β-glucans and mammalian immunity. Immunity 19: 311-315, 2003.
10. BRUMMER E, HANSON LH, RESTREPO A, STEVENS DA: Intracellular multiplication of Paracoccidioides brasiliensis in macrophages: killing and restriction of multiplication by activated macrophages. Infect Immun 57: 2289-2294, 1989.
11. CALICH VLG, VAZ CA, BURGER E: Immunity to Paracoccidioides brasiliensis infection. Res Immunol 149: 407-417, 1998.
12. CALVI SA, PERAÇOLI MTS, MENDES RP, MARCONDES-MACHADO J, FECCHIO D, MARQUES SA, SOARES AMVC: Effect of cytokines on the in vitro fungicidal activity of monocytes from paracoccidiodomycosis patients. Microbes Infect 5: 107-113, 2003.
13. CHIRIGOS MA, STYLOS WA, SCHULTZ RM, FULLEN JR: Chemical and biological adjuvants capable of potentiating tumor cell vaccine. Cancer Res 38: 1085-1091, 1978.
14. DI LUZIO NR, WILLIAMS DL. Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect Immun, 20: 804-810, 1978.
15. DI LUZIO NR, WILLIAMS DL: The role of glucan in the prevention and modification of microparasitic diseases. Chem Reg Immun Vet Med 161: 443-456, 1984.
16. DI LUZIO NR, WILLIAMS DL, MCNAMEE RB, EDWARDS BF, KITAHAMA A: Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer 24: 773-779, 1979.
17. ENGSTAD CS, ENGSTAD RE, OLSEN JO, OSTERUD B: The effect of soluble β-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int Immunopharmacol 2: 1585-1597, 2002.
18. ESTRADA A, YUN CH, KESSEL AV, LI B, HAUTA S, LAARVELD B: Immunomodulatory activities of oat β-glucan in vitro and in vivo. Microbiol Immunol 41: 991-998, 1997.
19. GATELY MK, RENZETTI LM, MAGRAM J: The interleukin-12/interleukin-12- receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16: 495-521, 1998.
20. HASSID WZ, JOSLYN MA, MCCREADY RM: The molecular constitution of an insoluble polysaccharide from yeast, Saccharomyces cerevisiae. J Am Chem Soc 63: 295-298, 1941.
21. HOFER M, POSPÍSIL M: Glucan as stimulator of hematopoiesis in normal and gamma-irradiated mice. A survey of the authors' results. Int J Immunopharmacol 19: 607-609, 1997.
22. HOGAN LH, KLEIN BS: Altered expression of surface α-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect Immun 62: 3543-3546, 1994.
23. HOLBROOK TW, COOK JA, PARKER BW. Immunization against Leishmania donovani: glucan as an adjuvant with killed promastigotes: Am J Trop Med Hyg 30: 762-768, 1981.
24. ITANO EN, UNO J, SANO A, YARITA K, KAMEI K, MIYAJI M, NISHIMURA K, MIKAMI Y: Detection of the gp43 gene and (1-3)-beta-D-glucan of Paracoccidioides brasiliensis in the blood of experimentally infected mice. Nippon Ishinkin Gakkai Zasshi 43: 29-35, 2002.
25. KANENO R, FONTANARI LM, SANTOS AS, DI STASI LC, RODRIGUES-FILHO E EIRA AF: Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice. Food Chem Toxicol 42: 909-916, 2004.
26. KLIMPEL RK, GOLDMAN WE: Cell walls from avirulent variants of Histoplasma capsulatum lack alpha-(1,3)-glucan. Infect Immun 56: 2997-3000, 1988.
27. KOBAYASHI M, FITZ L, RYAN M, HEWICK RM, CLARK SC, CHAN S, LOUDON R, SHERMAN F, PERUSSIA B, TRINCHIERI G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170: 827-845, 1989.
28. KURIHARA K, SHINGO Y, MIURA NN, HORIE S, USUI Y, ADACHI Y, YADOMAE T, OHNO N: Effect of CAWS, a mannoprotein-beta-glucan complex of Candida albicans, on leukocyte, endothelial cell, and platelet functions in vitro. Biol Pharm Bull 26: 233-240, 2003.
29. LEE JN, LEE DY, JI IH, KIM GE, KIM HN, SOHN J, KIM S, KIM CW: Purification of soluble β-glucan with immune-enhancing activity from the cell wall of yeast. Biosci Biotechnol Biochem 65: 837-841, 2001.
30. LEENEN PJ, CANONO BP, DREVETS DA, VOEMAN JS, CAMPBELL PA: TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner. J Immunol 153: 5141-5147, 1994.
31. LOTZOVÁ E, GUTTERMAN JU: Effect on natural killer (NK) cells: further comparison between NK cell and bone marrow effector cell activities. J Immunol 123: 607-611, 1979.
32. MACKIN WM, BRUNKE-REESE D, GU Y, CROTTY C, FISETTE L: Enhanced microbial activities of human peripheral blood monocytes and neutrophils (PMN) after pre-treatment with PGG-glucan (Betafectin™). FASEB J 8: A216, 1994.
33. MASIHI KN, MADAJ K, HINTELMANN H, GAST G, KANEKO Y: Down-regulation of tumor necrosis factor-α, moderate reduction of interleukin-1β, but not interleukin-6 or interleukin-10, by glucan immunomodulators curdlan sulfate and lentinan. Int J Immunopharmacol 19: 463-468, 1997.
34. MEIRA DA, PEREIRA PCM, MARCONDES-MACHADO J, MENDES RP, BARRAVIERA B, PELLEGRINO JRJ, REZKALLAH-IWASSO MT, PERA̧COLI MTS, CASTILHO LM, THOMAZINI I, SILVA CL, FOSS NT, CURI PR: The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis. Am J Trop Med Hyg 55: 496-503, 1996.
35. OHNO N, ASADA N, ADACHI Y, YADOMAE T: Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1→3)-beta-D-glucans in mice. Biol Pharm Bull 18: 126-133, 1995.
36. OLSON EJ, STADING JE, GRIECO-HARPER N, HOFFMAN AO, LIMPER AH: Fungal β-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophages. Infect Immun 64: 3548-3554, 1996.
37. POUTSIAKA DD, MENGOZZI M, VANNIER E, SINHA B, DINARELLO CA: Cross-linking of the β-glucan receptor on human monocytes results in interleukin-1 production. Blood 12: 3695-3700, 1993.
38. ROMANO CC, MENDES-GIANNINI MJS, DUARTE AJS, BERNARD G: IL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific cellular immunosuppression of paracoccidioidomycosis patients. Cytokine 18: 149-157, 2002.
39. SANDULA J, KOGAN G, KACURÁKOVÁ M, MACHOVÁ E: Microbial (1→3)-D-glucans, their preparation, physico-chemical characterization and immunomodulatory activity. Carbohydr Polym 38: 247-253, 1999.
40. SOLTYS J, QUINN MT: Modulation of enterotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan. Infect Immun 67: 244-252, 1999.
41. SOUTO JT, FIGUEIREDO F, FURLANETTO A, PFEFFER K, ROSSI MA, SILVA JS: Interferon-γ and tumor necrosis factor-α determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol 156: 1811-1820, 2000.
42. TRINCHIERI G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251-276, 1995.
43. TZIANABOS AO: Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13: 523-533, 2000.
44. VASSALLO R, KOTTOM TJ, STANDING JE, LIMPER AH: Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. Am J Respir Cell Mol Biol 25: 203-211, 2001.
45. VETVICKA V, THORNTON BP, ROSS GD: Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 98: 50-61, 1996.
46. WAKSHULL E, BRUNKE-REESE D, LINDERMUTH J, FISETTE L, NATHANS RS, CROWLEY JJ, TUFTS JC, ZIMMERMAN J, MACKIN W, ADAMS DS: PGG-Glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: evidence for a glycosphingolipid β-(1,3)-glucan receptor. Immunopharmacology 41: 89-107, 1999.
47. WANKE B, LONDERO AT: Epidemiology and paracoccidioidomycosis infection. In: Paracoccidioidomycosis. FRANCO M, LACAZ CS, RESTREPO-MORENO A, DEL NEGRO G (eds), CRC Press, Boca Raton, 1994, pp 109-120.